CTRI/2013/11/004172已完成3 期
Evaluation of Memantine for migraine prophylaxis
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with of migraine as assessed by International Headache Society (IHS) criteria, for at least 6 months before screening
- •patients with between 3 and 12 migraines but no more than 15 headache days
- •Patients willing to give consent
排除标准
- •Patients having headaches other than migraine, episodic tension, or sinus headaches.
- •If headaches failed to respond to more than 2 adequate previous regimens of migraine preventive medications
- •Medication overuse headache
- •Pregnant/breast feeding women
- •Severe medical illness
- •renal insufficiency
- •Hypersensitivity
研究者
相似试验
已完成
3 期
The effect of Memantine in migraine patientsMigraineIRCT20171230038142N21Esfahan University of Medical Sciences84
已完成
3 期
Evaluation of the effect of memantine for the prevention of headaches caused by head traumapost traumatic headache.post traumatic headacheG44.3IRCT20201005048944N1Esfahan University of Medical Sciences90
尚未招募
不适用
Treating with magnesium in migraine patients with magnesium defiencyCTRI/2020/05/025454Vinayaka missions medical college and hospital
招募中
4 期
A clinical trial to study the effects of two doses of the drug, amitriptyline in patients with Migraine.CTRI/2014/01/004302Sree Mookambika Institute of Medical Sciences82
已完成
3 期
Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine.Migraine HeadacheNCT04698525Universidad Autonoma de San Luis Potosí33
